Holen Sie sich die Stockscreener-App
54.08
1.50%
0.80
Handel nachbörslich:
54.08
Schlusskurs vom Vortag:
$53.28
Offen:
$53.29
24-Stunden-Volumen:
864.66K
Relative Volume:
1.13
Marktkapitalisierung:
$2.61B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
22.44
EPS:
2.41
Netto-Cashflow:
$20.35M
1W Leistung:
-0.48%
1M Leistung:
-29.12%
6M Leistung:
-18.06%
1J Leistung:
-27.89%
1-Tages-Spanne:
$52.58
$54.13
1-Wochen-Bereich:
$52.58
$55.12
52-Wochen-Spanne:
$50.68
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
54.08 | 2.58B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Bestätigt | Barrington Research | Outperform |
| 2025-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Applying big data sentiment scoring on Haemonetics CorporationTrade Ideas & Verified Technical Signals - Newser
How sentiment analysis helps forecast Haemonetics CorporationGlobal Markets & Smart Money Movement Tracker - Newser
What candlestick patterns are forming on Haemonetics CorporationJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Is Haemonetics Corporation a candidate for recovery playTrade Volume Summary & Weekly High Momentum Picks - Newser
Is Haemonetics Corporation a top pick in the sectorIndex Update & AI Based Buy/Sell Signal Reports - khodrobank.com
How to escape a deep drawdown in Haemonetics CorporationMarket Trend Summary & Entry Point Confirmation Alerts - Newser
Can Haemonetics Corporation reach all time highs this yearWeekly Trade Review & Daily Entry Point Trade Alerts - khodrobank.com
Will Haemonetics Corporation benefit from AI trendsGap Up & Safe Entry Zone Identification - khodrobank.com
Is Haemonetics Corporation stock ready for a breakout2025 Key Lessons & Weekly Watchlist for Hot Stocks - Newser
Published on: 2025-09-02 04:04:11 - Newser
Is this a good reentry point in Haemonetics CorporationOil Prices & Precise Buy Zone Identification - Newser
Can Haemonetics Corporation weather a recession2025 Trade Ideas & AI Driven Price Forecasts - khodrobank.com
Analyzing Haemonetics Corporation with multi timeframe chartsJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
What moving averages say about Haemonetics CorporationTrade Analysis Report & Momentum Based Trading Ideas - Newser
Using Python tools to backtest Haemonetics Corporation strategiesLong Setup & Expert Verified Movement Alerts - Newser
Can machine learning forecast Haemonetics Corporation recoveryQuarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Can Haemonetics Corporation hit a new high this monthPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Should You Be Excited About Haemonetics Corporation's (NYSE:HAE) 19% Return On Equity? - ca.finance.yahoo.com
Volatility clustering patterns for Haemonetics Corporation2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Published on: 2025-09-01 20:53:08 - Newser
Analyzing net buyer seller activity in Haemonetics CorporationJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Why Haemonetics Corporation stock attracts strong analyst attentionMarket Performance Report & Advanced Technical Signal Analysis - Newser
Building trade automation scripts for Haemonetics Corporation2025 Big Picture & Real-Time Price Movement Reports - Newser
Is Haemonetics Corporation stock entering bullish territoryOil Prices & Verified Swing Trading Watchlist - Newser
Haemonetics Corporation $HAE Shares Sold by Northern Trust Corp - Defense World
Zacks Research Lowers Earnings Estimates for Haemonetics - Defense World
Evaluating Haemonetics Corporation with trendline analysisJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Haemonetics Corporation Approaches Support With Recovery in SightOil Prices & High Accuracy Swing Entry Alerts - beatles.ru
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):